Results 21 to 30 of about 1,895,251 (293)
Levodopa-carbidopa intestinal gel therapy in Parkinson’s disease: Procedure complications [PDF]
Romanian Journal of Neurology, 2020 Objectives. Continuous delivery of levodopa-carbidopa intestinal gel (LCIG) represents a gold standard option for the treatment of advanced PD and the benefits of intestinal gel delivery are significative superior from those obtained with available ...
Luminita Celia Popa +4 more
doaj +1 more source
Journal of Clinical Pathology, 2017 Programmed death ligand 1 (PD-L1) is the principal ligand of programmed death 1 (PD-1), a coinhibitory receptor that can be constitutively expressed or induced in myeloid, lymphoid, normal epithelial cells and in cancer. Under physiological conditions, the PD-1/PD-L1 interaction is essential in the development of immune tolerance preventing excessive ...
Kythreotou A. +4 more
openaire +4 more sources
MANAS: Journal of Engineering, 2020 In this study, carbon nanotube (CNT) supported Pd catalysts at varying Pd molar ratios are prepared via NaBH4 reduction method. Catalysts prepared for hydrazine electrooxidation are characterized via N2 adsorption-desorption measurements (BET), X-ray ...
Hilal Demir Kıvrak +3 more
doaj +1 more source
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
Diabetes, Metabolic Syndrome and Obesity, 2021 Xiaomin Xie,* Guirong Bai,* Huili Liu, Li Zhang, YanTing He, Dan Qiang, Xiaoyan Zou Department of Endocrinology, The First People’s Hospital of Yinchuan, Yinchuan, 750001, People’s Republic of China*These authors contributed equally to this ...
Xie X +6 more
doaj
Impact of type 2 diabetes mellitus on severity of Parkinson's disease: a cross-sectional study [PDF]
Romanian Journal of NeurologyBackground and objectives. Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that significantly impact quality of life.
Ahmed Hamdy +3 more
doaj +1 more source
, 2022 While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source
Pd/Pt IMBALANCE IN LAVAS AND INTRUSIONS OF THE NORILSK-TALNAKH ORE REGION
Геодинамика и тектонофизика, 2021 The paper considers the Pd/Pt ratio in the ores of the Norilsk-1 and Talnakh deposits associated with the Permian-Triassic intrusions of the Norilsk type in comparison with that in the lavas of the same age in the Norilsk region.
T. V. Dudkin +3 more
doaj +1 more source
, 2022 While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source
PD-1 and PD-L1 antibodies for melanoma [PDF]
Human Vaccines & Immunotherapeutics, 2014 Melanoma is the most serious form of skin cancer. Metastatic melanoma historically carries a poor prognosis and until recently there have been few effective agents available to treat widely disseminated disease. Recognition of the immunogenic nature of melanoma has resulted in the development of various immunotherapeutic approaches, especially with ...
Tsai, Katy K +2 more
openaire +4 more sources
, 2022 While anti-PD-1 and anti-PD-L1 [anti-PD-(L)1] monotherapies are effective treatments for many types of cancer, high variability in patient responses is observed in clinical trials.
Jessica C. Leete (14213357) +4 more
core +1 more source